ACRIN-Contralateral-Breast-MR (ACRIN 6667)

This dataset relates to NCI Clinical trial, "Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer (ACRIN-6667)". Even after careful clinical and mammographic evaluation, cancer is found in the contralateral breast in up to 10% of women who have received treatment for unilateral breast cancer. ACRIN 6667 was conducted to determine whether magnetic resonance imaging (MRI) could improve on clinical breast examination and mammography in detecting contralateral breast cancer soon after the initial diagnosis of unilateral breast cancer. A total of 969 women with a recent diagnosis of unilateral breast cancer and no abnormalities on mammographic and clinical examination of the contralateral breast underwent breast MRI.本数据集关联美国国家癌症研究所（National Cancer Institute, NCI）的一项临床试验——“新近确诊单侧乳腺癌女性的磁共振成像研究（ACRIN-6667）”。即便经过细致的临床检查与乳腺钼靶评估，接受单侧乳腺癌治疗的女性中仍有高达10%的比例会在对侧乳腺检出癌症。本项ACRIN 6667研究旨在探究，在单侧乳腺癌初诊后短期内，磁共振成像（magnetic resonance imaging, MRI）是否能够优化临床乳腺检查与乳腺钼靶筛查对侧乳腺癌的检出效果。总计969名新近确诊单侧乳腺癌，且对侧乳腺的钼靶与临床检查未发现异常的女性接受了乳腺磁共振成像检查。